{
    "Trade/Device Name(s)": [
        "NIOX MINO"
    ],
    "Submitter Information": "Aerocrine AB",
    "510(k) Number": "K101034",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072816"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "August 2, 2010",
    "Summary Letter Received Date": "August 6, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3080"
    ],
    "Regulation Name(s)": [
        "Breath Nitric Oxide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "POCT"
    ],
    "Analyte(s)": [
        "Nitric Oxide (NO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NIOX MINO"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Non-invasive breath analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Monitoring System"
    ],
    "Document Summary": "FDA 510(k) summary for NIOX MINO handheld system for quantitative measurement of nitric oxide in expired human breath for asthma management",
    "Indications for Use Summary": "NIOX MINO measures nitric oxide in human breath to evaluate asthma patients\u2019 response to anti-inflammatory therapy, suitable for children 7\u201317 years and adults 18+ years, as adjunct to established assessments; not for infants or children under 7, critical care, emergency care, or anaesthesiology",
    "fda_folder": "Toxicology"
}